Skip to main content

Table 3 Distribution of implants over the groups (by indication)

From: A retrospective analysis of the risk factors for surgical site infections and long-term follow-up after transpalpebral enucleation in horses

 

No implant

Implant

Total (P < 0.001*)

Indication

 Group 1: clean eye

21 (36.2%)

37 (63.8%)

58 (54.2%)

 Group 2: non-clean eye

22 (71%)

9 (29%)

31 (29%)

 Group 3: tumour

15 (83.3%)

3 (16.7%)

18 (16.8%)

 Total

58 (54.2%)

49 (45.8%)

107 (100%)

  1. * P-value from Fisher’s exact test